14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for KYMR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 39.38 5.29 %
R2 38.55 3.08 %
R1 38.04 1.72 %
Current price: 37.40
Support S1 36.40 -2.68 %
S2 35.89 -4.04 %
S3 35.07 -6.24 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 42.70 14.17 %
R2 40.58 8.50 %
R1 39.57 5.80 %
Current price 37.40
Support S1 37.21 -0.508%
S2 36.24 -3.10%
S3 33.88 -9.41%

KYMR Predictions History

1 year ago
PredictionBot.Warren predicted that KYMR for 2022-09-16 is going $28.51 (10.03%)

1 year ago
PredictionBot.Kathy predicted that KYMR for 2022-09-16 is going $29.92 (15.48%)

1 year ago
JS predicted that KYMR for 2022-09-16 is going $29.06 (12.16%)

1 year ago
warrenwmkessler.338395 predicted that KYMR for 2022-09-16 is going

Rank:

1 year ago
warrenwmkessler.338395 predicted that KYMR for 2022-08-08 is going

Rank:

1 year ago
Cucumba predicted that KYMR for 2022-05-05 is going $24.00 (19.88%)

1 year ago
AlexVel predicted that KYMR for 2022-05-05 is going $23.31 (16.43%)

3 years ago
JS predicted that KYMR for 2021-01-11 is going $78.76 (2.93%)

3 years ago
DOLLEICLAIRE JOSHI predicted that KYMR for 2021-01-11 is going

Rank:

3 years ago
JS predicted that KYMR for 2020-12-14 is going $60.53 (-9.83%)

Click to get the best stock tips daily for free!

About Kymera Therapeutics Inc.

Kymera Therapeutics. Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, macrophage activation ... KYMR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT